Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/150482
Full metadata record
DC FieldValueLanguage
dc.creatorCastro, I
dc.creatorSampaio-Marques, B
dc.creatorAreias, AC
dc.creatorSousa, H
dc.creatorFernandes, Â
dc.creatorSanchez-Maldonado, JM
dc.creatorCunha, C
dc.creatorCarvalho, A
dc.creatorSainz, J
dc.creatorLudovico, P
dc.date.accessioned2023-06-27T13:24:47Z-
dc.date.available2023-06-27T13:24:47Z-
dc.date.issued2021
dc.identifier.issn2072-6694
dc.identifier.urihttps://hdl.handle.net/10216/150482-
dc.description.abstractAcute myeloid leukemia (AML) is the most common acute leukemia, characterized by a heterogeneous genetic landscape contributing, among others, to the occurrence of metabolic repro-gramming. Autophagy, a key player on metabolism, plays an essential role in AML. Here, we examined the association of three potentially functional genetic polymorphisms in the ATG10 gene, central for the autophagosome formation. We screened a multicenter cohort involving 309 AML patients and 356 healthy subjects for three ATG10 SNPs: rs1864182T>G, rs1864183C>T and rs3734114T>C. The functional consequences of the ATG10 SNPs in its canonical function were in-vestigated in vitro using peripheral blood mononuclear cells from a cohort of 46 healthy individu-als. Logistic regression analysis adjusted for age and gender revealed that patients carrying the ATG10rs1864182G allele showed a significantly decreased risk of developing AML (OR [odds ratio] = 0.58, p = 0.001), whereas patients carrying the homozygous ATG10rs3734114C allele had a significantly increased risk of developing AML (OR = 2.70, p = 0.004). Functional analysis showed that individuals carrying the ATG10rs1864182G allele had decreased autophagy when compared to homozygous major allele carriers. Our results uncover the potential of screening for ATG10 genetic variants in AML prevention strategies, in particular for subjects carrying other AML risk factors such as elderly individuals with clonal hematopoiesis of indeterminate potential.
dc.description.sponsorshipThis research was funded by FEDER and Foundation for Science and Technology (FCT), grant number POCI-01-0145-FEDER-028159 and POCI-01-0145-FEDER-030782); by Fondo de Inves-tigaciones Sanitarias (Madrid, Spain), grant number ISCIII-FEDER PI20/01845, ISCIII-FEDER PI12/02688, and ISCIII-FEDER PI17/02276. B.S.M. was funded by FCT, grant number DL 57/2016. A.C.A. was funded by FCT, grant number POCI-01-0145-FEDER-028159. C.C. was funded by FCT, grant number CEECIND/04058/2018. A.C. was funded by FCT, grant number CEEC-IND/03628/2017.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofCancers, vol.13(6):1344
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleFunctional genetic variants in atg10 are associated with acute myeloid leukemia
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.3390/cancers13061344
dc.relation.publisherversionhttps://www.mdpi.com/2072-6694/13/6/1344
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3390-cancers13061344.pdf2.07 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons